Precision Drug Development
Accelerate drug development timelines, reduce risks and lower costs
Our biosimulation platform predicts human clinical response to investigational drug candidates YEARS earlier than traditional development pipelines
Use biosimulation technology to get more investigational agents to market faster
REDUCE
Risks
BOOST
Revenues
ACCELERATE
Timelines
IMPROVE
ROI
Our drug development biosimulation methodology
The Cellworks Platform is powered by the groundbreaking Cellworks Computational Biology Model (CBM), a network of 6,000+ human genes, 30,000+ molecular species and 600,000+ molecular interactions.
Cellworks precision drug development addresses key industry challenges
Improve drug success rates through biomarker development
Identify companion molecules to expand the utility of a drug
Expand indications for drugs at the pre-clinical stage
